We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease.
- Authors
Chen, Shuchun; Yu, Seong-Jin; Li, Yazhou; Lecca, Daniela; Glotfelty, Elliot; Kim, Hee Kyung; Choi, Ho-Il; Hoffer, Barry J.; Greig, Nigel H.; Kim, Dong Seok; Wang, Yun
- Abstract
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
- Publication
Scientific Reports, 2018, Vol 8, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-018-31455-w